Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...

Learn more about how myelin springs back in the brain after a marathon and how these findings could help people with multiple ...

Quantum BioPharma (NASDAQ: QNTM) has announced that its licensee, Celly Nutrition Corporation, is launching the alcohol-mitigating beverage unbuzzdT ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

“This confirmation by our talented team of researchers demonstrates that fibroblasts can support the regeneration of myelin sheath, marking a potentially significant step in the utilization of a ...

Multiple sclerosis is a long-term disease that damages the brain and spinal cord. It happens when the immune system attacks ...

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusett ...

Approximately 1 million people in the U.S. are living with multiple sclerosis (MS). While the symptoms usually appear when people are in the prime of their lives — between the ...

Eleven foals in the Pacific Northwest were diagnosed with a condition called Equine Juvenile Spinocerebellar Ataxia (EJSCA).

New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...